Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices $1B of Senior Notes

NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced after the close of the market on Monday that it has priced $1 billion of senior notes.

The Waltham, Massachusetts-based scientific products giant's 3 percent senior notes are paid on a semi-annual basis, and are due in 2023. The issue price is 99.512 percent of the principal amount.

The firm plans to use the proceeds, along with cash on hand, to redeem all of its outstanding $1 billion 2.25 percent senior notes that mature August 15. Thermo Fisher said it expects the issuance to close on or about April 13, subject to closing conditions.

Merrill Lynch, Pierce, Fenner & Smith, Goldman Sachs, and Morgan Stanley acted as joint book-running managers for the offering.

Fitch Ratings granted the senior notes a BBB rating with a Stable rating outlook on Monday.

In Tuesday morning trading on the New York Stock Exchange, shares of Thermo Fisher were trading down less than 1 percent at $142.79.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.